Navigating the Nagoya Protocol with Dr. Mukul Ranjan

The Nagoya Protocol is a supplement to the United Nation’s Biodiversity Treaty, and it is reshaping the landscape of scientific research. In this episode, Dr. Mukul Ranjan, a Senior Advisor for Innovation and Technology Transfer at the National Institute of Allergy and Infectious Diseases (NIAID), is here to explain how. As a key player in fostering collaborations between the public, private, academic, and non-profit sectors, Dr. Ranjan has firsthand knowledge of how the Nagoya Protocol is impacting scientific research. During this episode, you’ll gain insights into, among other things, the reasons for the development of the Nagoya Protocol, the challenges of the regulatory landscape now that the Nagoya Protocol is being widely implemented in 130 countries across the globe, and why the US isn’t party to the Nagoya Protocol. In This Episode:[01:17] Introducing Dr. Mukul Ranjan, a Senior Advisor for NIAID.[02:36] The purpose of the Nagoya Protocol.[05:15] Dr. Ranjan’s thoughts on why a growing number of countries have begun to implement the Nagoya Protocol in recent years. [06:30] Challenges of conducting international infectious disease research within the new regulatory landscape. [09:08] How scientists are adapting to the new regulations that are being implemented as a result of the Nagoya Protocol. [13:13] Dr. Ranajn’s advice for navigating the Nagoya Protocol. [16:39] Why the US has chosen not to become a party to the Nagoya Protocol and the implications of this.[22:56] The core principles that the Nagoya Protocol was founded upon. [24:36] Examples of the benefits that the Nagoya Protocol promises. [02:34] How Dr. Ranjan believes the Nagoya Protocol will impact international research collaborations in the future. [28:20] The value of open science. [29:54] How to foster effective international collaboration in scientific research. Resources:Dr. Mukul Ranjan on LinkedInConvention on Biological DiversityGerman Nagoya Protocol HuBAmerican Institute of Biological SciencesThe Nagoya Protocol Learning Portal‘ABS from the Perspective of an Intellectual Property Professional at a Public Research Institution’ 

There are no comments yet.

Please log in to write the first comment.